Marshall Wace, LLP Nuvasive Inc Transaction History

Marshall Wace, LLP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$36.71 - $44.15 $8.68 Million - $10.4 Million	236,572 Added 553.54%	279,310 $11.6 Million
Q1 2023 May 15, 2023	BUY	$36.81 - $48.12 $1.57 Million - $2.06 Million	42,738 New	42,738 $1.77 Million
Q1 2022 May 16, 2022	SELL	$48.09 - $57.79 $1.3 Million - $1.57 Million	-27,117 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$47.19 - $62.68 $922,942 - $1.23 Million	-19,558 Reduced 41.9%	27,117 $1.42 Million
Q2 2021 Aug 13, 2021	BUY	$64.02 - $71.72 $2.66 Million - $2.98 Million	41,508 Added 803.33%	46,675 $3.16 Million

Q1 2021 May 17, 2021	BUY	$53.26 - $68.08 $275,194 - $351,769	5,167 New	5,167 $339,000
Q1 2020 May 15, 2020	SELL	$32.82 - $81.13 $545,763 - $1.35 Million	-16,629 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$60.96 - $77.7 $46,817 - $59,673	768 Added 4.84%	16,629 $1.29 Million
Q3 2019 Nov 14, 2019	SELL	$55.78 - $68.08 $1.9 Million - $2.32 Million	-34,144 Reduced 68.28%	15,861 $1.01 Million
Q2 2019 Aug 14, 2019	BUY	$53.69 - $65.47 $2.68 Million - $3.27 Million	50,005 New	50,005 $2.93 Million
Q1 2019 May 14, 2019	SELL	$44.53 - $58.9 $1.63 Million - $2.15 Million	-36,566 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$47.64 - $71.26 $1.74 Million - $2.61 Million	36,566 New	36,566 $1.81 Million
Q3 2018 Nov 14, 2018	SELL	$52.03 - $71.41 $7.6 Million - $10.4 Million	-146,099 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$48.15 - $56.68 $6.7 Million - $7.89 Million	139,127 Added 1995.51%	146,099 $7.62 Million
Q1 2018 May 15, 2018	BUY	$46.03 - $61.28 $320,921 - $427,244	6,972 New	6,972 $364,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.